TATA Health International Holdings Limited announced that there may be a delay in publication of the Company's annual results announcement for the year ended 31 December 2023 (the ``2023 Annual Results'') because, as at the date of this announcement, the Company is still in the process of collecting and collating the necessary information and documents from its subsidiaries as required by the auditor of the Company, HLB Hodgson Impey Cheng Limited (the ``Auditor'') to complete the auditing process, and hence additional time is required for the Company to prepare the 2023 Annual Results. The Company is working closely with its subsidiaries and the Auditor to gather all requisite information and documents to complete the audit procedures as soon as possible. However, the expected date of the publication of the 2023 Annual Results will need to be further discussed and determined with the Auditor and will be announced as and when appropriate.

Though the delay in publication of the 2023 Annual Results and the despatch of the 2023 Annual Report would constitute non-compliance of Rules 13.49(1) and 13.46(2) of the Listing Rules, the Board wishes to emphasise that the operations of the Group remain normal, and the Company will use its best endeavours to publish the 2023 Annual Results as soon as possible. The Company expects to publish the 2023 Annual Results in the end of April 2024.